Simpson, E.; Blauvelt, A.; Guttman-Yassky, E.; Worm, M.; Lynde, C.; Saeki, H.; Poulin, Y.; Wollenberg, A. Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients With Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2). J of Skin 2020, 4, s96.